MarketPulse

FDA regulations

2 articles
Investing.comInvesting.com··Jessica Mitacek

Hims & Hers Pivots to Brand-Name GLP-1s as Novo Deal Reshapes Growth Strategy

Hims & Hers reports Q1 earnings May 11 after settling patent dispute with Novo Nordisk, gaining rights to sell Wegovy and Ozempic while discontinuing compounded alternatives.
NVOHIMSGLP-1 drugsFDA regulations
GlobeNewswire Inc.GlobeNewswire Inc.··Towards Packaging

U.S. Clinical Trial Packaging Market Set to Nearly Triple by 2035

U.S. clinical trial packaging market expected to nearly triple to $2.7 billion by 2035, driven by increased R&D spending and demand for advanced, specialized packaging solutions.
AMCRsustainable packagingclinical trial packaging